As AKT, through inhibiting GSK-3β, can also stabilise c-MYC, it was of interest that while this manuscript was in preparation, Liu et al published a study reporting that BCL-3 stabilises c-MYC in HCT116 colorectal cancer cells. The gene discussed is MYC; the disease is colorectal cancer.